WoundScribe AI
Share
X Facebook WhatsApp Email

Perfusion, HbA1c, and exclusions: the DFU data WoundScribe captures for coverage

product

Published

How WoundScribe pulls the perfusion, HbA1c, and exclusion data that determines whether a diabetic foot ulcer qualifies for advanced therapy coverage.

Advanced DFU therapies — topical oxygen, skin substitutes, HBO — all share the same eligibility spine: diabetes control, perfusion, and a clean exclusion list. WoundScribe's diabetic foot care workflow captures each element during the normal encounter, so coverage isn't a scramble at week four.

HbA1c capture and freshness

The AI scribe for wound care listens for HbA1c values spoken during the visit and reconciles them against lab feeds in the EMR. If the most recent value is stale or missing, the chart flags it before the visit closes.

Perfusion assessment, structured

Pulse exams, ABI, TBI, and TcPO2 results are parsed from the dictation into discrete fields tied to the correct limb. Payers want laterality — WoundScribe preserves it.

Exclusion screening

The system continuously watches the chart for exclusion diagnoses: osteomyelitis, gangrene, active infection, same-limb DVT, and malignancy. New findings surface immediately in the coverage view, so a wound that was eligible last week isn't billed as eligible this week if the picture has changed.

Everything tied to the wound, not just the patient

Because data attaches to the specific wound record, a patient with two DFUs on opposite feet doesn't get evaluated against the wrong limb's perfusion. Same for exclusion timing — resolved infections stop blocking coverage automatically once documentation supports it.

From structured data to a coverage decision

All of it feeds the healing dashboard so that when the four-week stall triggers, every supporting criterion is already in place — no chase, no denial.

Start your free trial at WoundScribe AI.